Drug Profile
Research programme: liver X receptor agonists - GlaxoSmithKline
Alternative Names: GW3965Latest Information Update: 04 Mar 2008
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Benzoic acids; Benzylamines
- Mechanism of Action Liver X receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Cardiovascular disorders
Most Recent Events
- 04 Mar 2008 Discontinued - Preclinical for Asthma in United Kingdom (unspecified route)
- 04 Mar 2008 Discontinued - Preclinical for Asthma in USA (unspecified route)
- 04 Mar 2008 Discontinued - Preclinical for Cardiovascular disorders in USA (unspecified route)